Avatar Medicine Forum 2023

Dr. Miser is an international expert in pediatric hematology/oncology, dedicated to innovative cancer treatments. He currently teaches at Taipei Medical University and he once led the City of Hope National Medical Center. In cancer research, he plays a pivotal role in various key committees, including the pediatric cancer research group and the Wilms tumor monitoring committee.

Luke Dimasi is a marketing and product management expert in the life sciences and biotechnology sector, with over 15 years of experience. He currently serves as the Senior Director of Product Management at Emulate, Inc. Deeply attuned to customer needs, he transforms them into successful strategies, leading teams to launch innovative products that elevate scientific research. With a background in cellular and molecular biology, Dimasi's expertise spans drug discovery, genomics, and areas like stem cell therapy.

Tony Chung is the CEO of Instant NanoBiosensors Co., Ltd., with extensive experience in the field of biotechnology. He entered the industry in 2002 and held key positions in several renowned companies, including Genetech biotech Co., Ltd in Taiwan, which represents Illumina. He is also a co-founder of Instant NanoBiosensors Co., Ltd. In 2020, he became a strategic partner of Merck KGaA. Mr. Tony Chung, with his outstanding leadership style and unwavering spirit of innovation, propels Instant NanoBiosensors Co., Ltd. forward, dedicating himself to the enhancement of the biotechnology industry.

Dr. Long-Sheng Lu is an Associate Professor at Taipei Medical University, concurrently holding positions in the Institute of Biomedical Materials and Tissue Engineering, Biomedical Engineering, and Regenerative Medicine Program. He is also an attending physician at Taipei Medical University Hospital and serves as the Director of the Cell Therapy Center.

Jack with 17+ years in Taiwan's biotech sector, Jack is a top genetic technology expert. He pioneered gene chips, NGS for clinics, and led vital projects like automated rare disease gene screening. His work linking genetics and medicine propels Taiwan's genetic medicine advancement.

Professor Yi-Hsuan Liu, based at National Taiwan University, focuses on animal development, regeneration, and stem cell research. By employing gene editing and genetic techniques, his work aims to decipher organogenesis mechanisms and develop strategies for effective tissue regeneration.

previously served as Exec. Director of Taiwan Sports and Fitness Industry Association's Innovation Committee and COO of Asia Sports Energy Group. Leading Uniigym, he innovates sports tech and fitness content, using gamification to lower barriers and promote a health-conscious lifestyle through interactive sensor fitness apps.

Dr. Liu is the Chief of Pediatric Oncology at Taipei Medical University Hospital and an Assistant Professor at Taipei Medical University. Specializing in neuroblastoma, pediatric oncology, and pediatric hematology, he has extensive experience in hematopoietic stem cell transplantation. He holds a medical degree from National Cheng Kung University and a Translational Medicine doctoral degree from National Taiwan University.

Dr. Chiu Chung-Feng is an esteemed expert in oncology and medical education. With a Ph.D. from the National Defense Medical Center, he's a distinguished professor at Taipei Medical University, focusing on radiation therapy, cancer research, and innovative treatments. His leadership spans hospital presidency and program directorship. Recognized with awards, including Outstanding Research Project and Excellent Teacher, Dr. Chiu's commitment to advancing cancer care, immunotherapy, and molecular biology makes him a pivotal figure in oncology.